TD Capital Management’s CareDx CDNA Stock Holding History

TD Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32	Closed	-$603	–	864
2025 Q4	$603	Hold	32	–	–	﹤0.01%	694
2025 Q3	$465	Hold	32	–	–	﹤0.01%	656
2025 Q2	$625	Hold	32	–	–	﹤0.01%	643
2025 Q1	$568	Buy	+32	New	+$689	﹤0.01%	586

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

TD Capital Management's CDNA Position: Q1 2026 in Review

TD Capital Management sold out of CareDx (CDNA) in Q1 2026, closing a stake of 32 shares — an estimated $603 sold.

TD Capital Management first reported a position in CDNA in Q1 2025 and held it in 4 quarters. The position peaked at $625 in Q2 2025. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

TD Capital Management reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
TD Capital Management sold 32 CareDx shares in Q1 2026, an estimated $603.
TD Capital Management first reported a position in CareDx in Q1 2025 and held it in 4 quarters.
TD Capital Management's CareDx position peaked at $625 in Q2 2025.
190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.